Page 68 - Read Online

Page 352 Estévez-Arias et al. J Transl Genet Genom 2022;6:333-52 https://dx.doi.org/10.20517/jtgg.2022.04

126. Chance PF, Alderson MK, Leppig KA, et al. DNA deletion associated with hereditary neuropathy with liability to pressure palsies.
Cell 1993;72:143-51. DOI PubMed
127. Bort S, Nelis E, Timmerman V, et al. Mutational analysis of the MPZ, PMP22 and Cx32 genes in patients of Spanish ancestry with
Charcot-Marie-Tooth disease and hereditary neuropathy with liability to pressure palsies. Hum Genet 1997;99:746-54. DOI PubMed
128. Braathen GJ, Sand JC, Lobato A, Høyer H, Russell MB. Genetic epidemiology of Charcot-Marie-Tooth in the general population.
Eur J Neurol 2011;18:39-48. DOI PubMed
129. Karadima G, Floroskufi P, Koutsis G, Vassilopoulos D, Panas M. Mutational analysis of PMP22, GJB1 and MPZ in Greek Charcot-
Marie-Tooth type 1 neuropathy patients. Clin Genet 2011;80:497-9. DOI PubMed
130. Paassen BW, van der Kooi AJ, van Spaendonck-Zwarts KY, Verhamme C, Baas F, de Visser M. PMP22 related neuropathies:
Charcot-Marie-Tooth disease type 1A and Hereditary Neuropathy with liability to Pressure Palsies. Orphanet J Rare Dis 2014;9:38.
DOI PubMed PMC
131. Boutary S, Echaniz-Laguna A, Adams D, et al. Treating PMP22 gene duplication-related Charcot-Marie-Tooth disease: the past, the
present and the future. Transl Res 2021;227:100-11. DOI PubMed
132. Li J, Parker B, Martyn C, Natarajan C, Guo J. The PMP22 gene and its related diseases. Mol Neurobiol 2013;47:673-98. DOI
PubMed PMC
133. Yuan JH, Hashiguchi A, Okamoto Y, et al. Clinical and mutational spectrum of Japanese patients with recessive variants in SH3TC2.
J Hum Genet 2018;63:281-7. DOI PubMed
134. Pérez-Garrigues H, Sivera R, Vílchez JJ, Espinós C, Palau F, Sevilla T. Vestibular impairment in Charcot-Marie-Tooth disease type
4C. J Neurol Neurosurg Psychiatry 2014;85:824-7. DOI PubMed
135. Claramunt R, Sevilla T, Lupo V, et al. The p.R1109X mutation in SH3TC2 gene is predominant in Spanish Gypsies with Charcot-
Marie-Tooth disease type 4. Clin Genet 2007;71:343-9. DOI PubMed
136. Laššuthová P, Mazanec R, Vondráček P, et al. High frequency of SH3TC2 mutations in Czech HMSN I patients. Clin Genet
2011;80:334-45. DOI PubMed
137. Azzedine H, Salih MA. SH3TC2-related hereditary motor and sensory neuropathy. 2008 Mar 31 [updated 2021 Mar 11]. In: Adam
MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle, WA: University of Washington, 1993-2022. PubMed
138. Lupo V, Galindo MI, Martínez-Rubio D, et al. Missense mutations in the SH3TC2 protein causing Charcot-Marie-Tooth disease type
4C affect its localization in the plasma membrane and endocytic pathway. Hum Mol Genet 2009;18:4603-14. DOI PubMed
139. Gouttenoire EA, Lupo V, Calpena E, et al. Sh3tc2 deficiency affects neuregulin-1/ErbB signaling. Glia 2013;61:1041-51. DOI
PubMed
140. Cortese A, Zhu Y, Rebelo AP, et al. Biallelic mutations in SORD cause a common and potentially treatable hereditary neuropathy
with implications for diabetes. Nat Genet 2020;52:473-81. DOI PubMed
141. Dong HL, Li JQ, Liu GL, Yu H, Wu ZY. Biallelic SORD pathogenic variants cause Chinese patients with distal hereditary motor
neuropathy. NPJ Genom Med 2021;6:1. DOI PubMed PMC
142. Liu X, He J, Yilihamu M, Duan X, Fan D. Clinical and genetic features of biallelic mutations in. SORD 2021;12:733926. DOI
PubMed PMC
143. Chen B, Zhang Z, Zhang C, et al. Clinical and pathological study of SORD-related distal motor neuropathy caused by novel
compound heterozygous mutations in a Chinese patient. Clin Neurol Neurosurg 2022;213:107118. DOI PubMed
144. Laššuthová P, Mazanec R, Staněk D, et al. Biallelic variants in the SORD gene are one of the most common causes of hereditary
neuropathy among Czech patients. Sci Rep 2021;11:8443. DOI PubMed PMC